Sebastien Maloveste

Corporate Officer/Principal at NEXTCURE, INC.

Health Technology

Consumer Services

Sebastien Maloveste active positions

Companies	Position	Start	End
NEXTCURE, INC.	Corporate Officer/Principal	-	-

Companies	Position	Start	End
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	-	-
GENVEC INC	Corporate Officer/Principal	01/01/2015	-

Universite De La Mediterranee

Doctorate Degree

International

United States	4
France	2

Operational

Corporate Officer/Principal	3
Doctorate Degree	1

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
NEXTCURE, INC.	Health Technology

Private companies	2
GenVec, Inc. GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD.	Health Technology
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Health Technology

Private companies

Health Technology